enVVeno Medical Corporation
NVNO
$3.63
$0.010.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.71% | -10.40% | -13.84% | 0.72% | 11.63% |
| Total Depreciation and Amortization | 0.00% | -5.43% | -5.15% | -3.55% | 5.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.62% | 13.94% | 4.07% | -10.55% | -13.84% |
| Change in Net Operating Assets | -259.70% | -155.83% | 621.74% | -120.00% | 132.81% |
| Cash from Operations | 21.29% | -19.39% | -9.42% | -10.08% | 28.61% |
| Capital Expenditure | -- | 55.56% | 35.71% | -40.00% | -150.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.06% | -277.43% | 56.19% | 80.62% | 109.97% |
| Cash from Investing | 147.04% | -277.75% | 56.52% | 80.80% | 109.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -99.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -100.00% | -99.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.32% | -204.03% | 23,437.88% | 105.05% | 1.51% |